Cannabis Health Studies

    Cannabis and Lung Health: What Smoke Does and Does Not Do

    Last updated: 5 min read
    Illustration of human lungs used to discuss cannabis smoke and respiratory health
    The bronchitis findings are solid. The cancer findings are not what people expect.

    Cannabis smoke and tobacco smoke share a great deal of chemistry. Both contain carbon monoxide, polycyclic aromatic hydrocarbons and other products of burning plant material. From that, most people reasonably assume the health consequences must line up too.

    They do not line up, and the way they diverge is genuinely interesting. One category of harm shows up consistently in the research. The other, the one everybody expects, has not.

    What the Evidence Consistently Shows

    Chronic bronchitis symptoms. Regular cannabis smoking is associated with cough, sputum production, wheeze and chest tightness. This is the most reproducible respiratory finding in the literature. The 2017 National Academies of Sciences, Engineering, and Medicine review concluded there was substantial evidence of an association between long-term cannabis smoking and worse respiratory symptoms and more frequent chronic bronchitis episodes.

    The encouraging part is that these symptoms appear largely reversible. Stopping smoking is followed by improvement, which is not the pattern seen with established tobacco-related structural damage.

    Airway inflammation. Bronchoscopic studies have found inflammatory changes in the large airways of cannabis smokers, consistent with the symptom picture.

    What the Evidence Has Not Shown

    Lung cancer. This is the finding that surprises people. Despite the shared carcinogens, large epidemiological studies have not produced the clear dose-dependent lung cancer association that tobacco produces. The National Academies review found the evidence insufficient to support or refute an association between cannabis smoking and lung cancer.

    Insufficient is not the same as absent, and it deserves to be read carefully rather than as a clean bill of health. Several factors complicate the picture: most cannabis smokers consume far fewer grams per day than cigarette smokers, many have also smoked tobacco, and cannabis has been illegal across most of the period being studied, which makes exposure history unreliable.

    Accelerated lung function decline. Tobacco produces a characteristic accelerated fall in FEV1 over time. Cannabis has not clearly reproduced this. Some studies have found increased forced vital capacity in cannabis smokers, possibly reflecting the deep inhalation and breath-holding common to the practice rather than any benefit.

    Why the Difference Might Exist

    Nobody has settled this, but the plausible contributors are worth stating:

  1. Dose. A heavy cigarette smoker gets through 20 cigarettes a day. A heavy cannabis smoker consumes a small fraction of that mass of plant material.
  2. No additives and no nicotine. Nicotine has its own biological effects, and manufactured cigarettes carry additives cannabis does not.
  3. Cannabinoid pharmacology. THC and CBD have effects on immune signalling and, in preclinical work, on tumour cell behaviour. Whether that offsets combustion carcinogens in humans is unresolved and should not be presented as established.
  4. COPD and Other Existing Lung Disease

    For anyone with COPD, asthma, cystic fibrosis or another chronic respiratory condition, the calculation changes. Smoking anything is contraindicated. Airways are already compromised, and combustion products aggravate exactly the mechanisms driving the disease.

    That does not automatically rule out cannabis, but it does rule out smoking it. Realistic alternatives:

  5. Oral routes including edibles, capsules and tinctures, which avoid the airway entirely. Slower onset and longer duration, which suits scheduled dosing better than breakthrough symptoms.
  6. Sublingual sprays and tinctures, faster than swallowing and still no inhalation.
  7. Topicals for localised musculoskeletal complaints, with no respiratory or systemic exposure.
  8. Vaporisers, which heat rather than burn and cut combustion by-products substantially. Lower risk than smoking is not the same as safe, and this option comes with its own caveat below.
  9. Anyone with a diagnosed respiratory condition should have this conversation with their pulmonologist rather than working it out alone, particularly because cannabis can interact with inhaled and oral medications.

    The Vaping Caveat

    Vaporising avoids combustion, and on that narrow measure it is an improvement. It is not a clean option.

    The 2019 EVALI outbreak, a wave of serious lung injury linked to vaping products, was traced substantially to vitamin E acetate used as a cutting agent in illicit-market THC cartridges. It was not caused by cannabis itself, and it was largely absent from tested regulated products. The lesson is about supply chain rather than about vaporisation as a technique.

    Long-term respiratory data on cannabis vaporisation remains limited, which is a genuine gap rather than reassurance.

    A Risk People Forget

    Cannabis flower can carry fungal contamination, including Aspergillus. For most people this is not a concern. For anyone immunocompromised, including transplant recipients and patients on chemotherapy, inhaling fungal spores is a real danger, and there are documented invasive infections. This population should avoid inhaled cannabis entirely and rely on tested oral products.

    Microbial screening is one of the panels on a certificate of analysis, and it is the panel that matters most here.

    Practical Risk Reduction

    If you are going to smoke, the changes that plausibly help: do not hold breath in, since the extra tar deposition buys no additional cannabinoid absorption; avoid mixing with tobacco, which adds nicotine dependence and tobacco's own risk profile; use a filter or a vaporiser; and treat a persistent productive cough as a reason to change route rather than something to live with.

    Bottom Line

    The bronchitis association is well supported and appears reversible on stopping. The lung cancer association that people expect has not materialised in the evidence, though the research has real limitations and that is not a green light. If you have existing lung disease, take the route out of your lungs, and if you are immunocompromised, avoid inhalation entirely.

    Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before making any health-related decisions.

    Frequently Asked Questions

    Does smoking cannabis cause lung cancer?

    The evidence has not shown it. The 2017 National Academies review found the evidence insufficient to support or refute an association, which is different from showing there is none. Lower consumed mass than cigarettes, overlapping tobacco use and unreliable exposure histories all complicate the research.

    What does cannabis smoking reliably do to the lungs?

    It causes chronic bronchitis symptoms: cough, sputum, wheeze and chest tightness. This is the most consistent respiratory finding, and the National Academies review rated the evidence for it as substantial. The symptoms appear largely reversible after stopping.

    Can you use cannabis if you have COPD?

    Not by smoking it, which is contraindicated with any chronic respiratory disease. Oral routes such as edibles, capsules and tinctures avoid the airway completely, sublingual products act faster, and vaporisers cut combustion products though they carry their own uncertainties. Discuss it with your pulmonologist.

    Was vaping cannabis behind the EVALI lung injuries?

    Not cannabis itself. The 2019 outbreak was traced substantially to vitamin E acetate used as a cutting agent in illicit-market THC cartridges, and it was largely absent from tested regulated products. It is a supply chain lesson rather than an argument against vaporisation as such.

    Share this article

    Further Reading